245 related articles for article (PubMed ID: 26940073)
1. Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy.
Piva F; Giulietti M; Santoni M; Occhipinti G; Scarpelli M; Lopez-Beltran A; Cheng L; Principato G; Montironi R
Mol Diagn Ther; 2016 Apr; 20(2):111-7. PubMed ID: 26940073
[TBL] [Abstract][Full Text] [Related]
2. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-mesenchymal transition in renal neoplasms.
He H; Magi-Galluzzi C
Adv Anat Pathol; 2014 May; 21(3):174-80. PubMed ID: 24713987
[TBL] [Abstract][Full Text] [Related]
4. Autophagy as a potential therapeutic target during epithelial to mesenchymal transition in renal cell carcinoma: An in vitro study.
Singla M; Bhattacharyya S
Biomed Pharmacother; 2017 Oct; 94():332-340. PubMed ID: 28772211
[TBL] [Abstract][Full Text] [Related]
5. Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines.
Mizumoto A; Yamamoto K; Nakayama Y; Takara K; Nakagawa T; Hirano T; Hirai M
J Pharmacol Exp Ther; 2015 Nov; 355(2):152-8. PubMed ID: 26306766
[TBL] [Abstract][Full Text] [Related]
6. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
[TBL] [Abstract][Full Text] [Related]
7. PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.
Massari F; Santoni M; Ciccarese C; Santini D; Alfieri S; Martignoni G; Brunelli M; Piva F; Berardi R; Montironi R; Porta C; Cascinu S; Tortora G
Cancer Treat Rev; 2015 Feb; 41(2):114-21. PubMed ID: 25586601
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
[TBL] [Abstract][Full Text] [Related]
9. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.
Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M
J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618
[TBL] [Abstract][Full Text] [Related]
10. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
11. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of nuclear factor kappa B in renal cell carcinoma.
Morais C; Gobe G; Johnson DW; Healy H
Int J Biochem Cell Biol; 2011 Nov; 43(11):1537-49. PubMed ID: 21854869
[TBL] [Abstract][Full Text] [Related]
13. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma.
Wang Y; Wang H; Zhao Q; Xia Y; Hu X; Guo J
Med Oncol; 2015 Aug; 32(8):212. PubMed ID: 26141060
[TBL] [Abstract][Full Text] [Related]
15. Everolimus suppresses invasion and migration of renal cell carcinoma by inhibiting FAK activity and reversing epithelial to mesenchymal transition in vitro and in vivo.
Wu SW; Chen PN; Lin CY; Hsieh YS; Chang HR
Environ Toxicol; 2017 Jul; 32(7):1888-1898. PubMed ID: 28258630
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.
Foroni C; Broggini M; Generali D; Damia G
Cancer Treat Rev; 2012 Oct; 38(6):689-97. PubMed ID: 22118888
[TBL] [Abstract][Full Text] [Related]
18. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
[TBL] [Abstract][Full Text] [Related]
19. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
[TBL] [Abstract][Full Text] [Related]
20. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
Harada K; Miyake H; Kusuda Y; Fujisawa M
BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
